X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (36) 36
humans (35) 35
female (33) 33
middle aged (23) 23
oncology (23) 23
adult (21) 21
breast neoplasms - drug therapy (21) 21
aged (17) 17
breast cancer (14) 14
breast neoplasms - pathology (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
tamoxifen - therapeutic use (8) 8
breast neoplasms - surgery (7) 7
chemotherapy (7) 7
medicine & public health (7) 7
abridged index medicus (6) 6
antineoplastic agents - therapeutic use (6) 6
cancer (6) 6
chemotherapy, adjuvant (6) 6
tamoxifen (6) 6
treatment outcome (6) 6
tumors (6) 6
antineoplastic agents, hormonal - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
cells (5) 5
neoadjuvant therapy (5) 5
postmenopausal women (5) 5
time factors (5) 5
women (5) 5
antineoplastic agents, hormonal - administration & dosage (4) 4
apoptosis (4) 4
breast neoplasms - genetics (4) 4
breast neoplasms - metabolism (4) 4
breast neoplasms - physiopathology (4) 4
breast neoplasms - prevention & control (4) 4
breast neoplasms - therapy (4) 4
combined modality therapy (4) 4
hematology (4) 4
lymph nodes - pathology (4) 4
lymphatic metastasis (4) 4
adjuvant chemotherapy (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - pharmacology (3) 3
biomarkers (3) 3
bone-mineral density (3) 3
breast neoplasms - diagnostic imaging (3) 3
carcinoma (3) 3
care and treatment (3) 3
chemoprevention (3) 3
clinical trials as topic (3) 3
combination (3) 3
disease-free survival (3) 3
doxorubicin - administration & dosage (3) 3
drug administration schedule (3) 3
endocrine therapy (3) 3
gene-expression (3) 3
hematopoiesis (3) 3
hematopoietic stem cell transplantation (3) 3
human necessities (3) 3
hygiene (3) 3
in-vivo (3) 3
incidence (3) 3
infusions, intravenous (3) 3
male (3) 3
mastectomy (3) 3
mastectomy, segmental (3) 3
medical or veterinary science (3) 3
neoadjuvant chemotherapy (3) 3
peripheral-blood (3) 3
pilot projects (3) 3
preparations for medical, dental, or toilet purposes (3) 3
prevention (3) 3
radiotherapy, adjuvant (3) 3
raloxifene (3) 3
selective estrogen receptor modulators - therapeutic use (3) 3
tamoxifen - administration & dosage (3) 3
administration, oral (2) 2
age (2) 2
age factors (2) 2
animals (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
area under curve (2) 2
article (2) 2
axilla (2) 2
biomarkers, tumor (2) 2
bone-marrow transplantation (2) 2
breast (2) 2
breast neoplasms - diagnosis (2) 2
breast neoplasms - epidemiology (2) 2
breast neoplasms - mortality (2) 2
carcinoma, ductal, breast - drug therapy (2) 2
carcinoma, ductal, breast - pathology (2) 2
carcinoma, lobular - drug therapy (2) 2
carcinoma, lobular - pathology (2) 2
clinical trials (2) 2
clinical trials as topic - standards (2) 2
cyclophosphamide - administration & dosage (2) 2
dark-adaptation (2) 2
diagnosis (2) 2
dose-response relationship, drug (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2003, Current problems in cancer, Volume 27, no. 6., 275-332
Book
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 21, pp. 2005 - 2014
Journal Article
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 612 - 612
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2007, Volume 88, Issue 6, pp. 1637 - 1644
Objective To assess the effects of raloxifene on the ovaries, uterus, and serum hormone levels in premenopausal women. Design Prospective study comparing... 
Internal Medicine | Obstetrics and Gynecology | premenopausal women | endometrium | breast cancer | ovary | Raloxifene | hormones | BONE-MINERAL DENSITY | PREVENTION | raloxifene | OVARIAN OVERSTIMULATION | TAMOXIFEN THERAPY | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | TRANSVAGINAL ULTRASONOGRAPHY | HIGH-RISK | BREAST-CANCER PATIENTS | REPLACEMENT THERAPY | POSTMENOPAUSAL WOMEN | UTERINE LEIOMYOMAS | Polyps - diagnostic imaging | Raloxifene Hydrochloride - adverse effects | Raloxifene Hydrochloride - therapeutic use | Humans | Middle Aged | Breast Neoplasms - etiology | Selective Estrogen Receptor Modulators - adverse effects | Gonadal Steroid Hormones - blood | Carcinoma - etiology | Premenopause - drug effects | Uterine Diseases - diagnostic imaging | Selective Estrogen Receptor Modulators - therapeutic use | Genitalia, Female - diagnostic imaging | Polyps - chemically induced | Ultrasonography | Adult | Female | Calcium Carbonate - administration & dosage | Drug Therapy, Combination | Drug Administration Schedule | Menstrual Cycle - blood | Risk Factors | Uterine Diseases - chemically induced | Carcinoma - prevention & control | Selective Estrogen Receptor Modulators - administration & dosage | Genitalia, Female - drug effects | Dehydroepiandrosterone Sulfate - blood | Breast Neoplasms - prevention & control | Raloxifene Hydrochloride - administration & dosage | Women | Menopause | Research institutes | Index Medicus
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2015, Volume 33, Issue 15, pp. 533 - 533
Conference Proceeding
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.